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Abstract 
We describe a 69-year-old male patient who was referred for the investigation of 
long-lasting fever, anemia and neutropenia. Hairy cell leukemia was diagnosed and 
treated successfully. However, fever persisted despite thorough investigation and use of 
broad-spectrum antibiotics. Four months after the initial diagnosis, the patient 
underwent explorative laparotomy and splenectomy. Spleen biopsy revealed multiple 
necrotizing mycobacterial granulomata while the patient’s fever disappeared 
permanently. Isolated splenic mycobacterial disease is very rare. This case report 
emphasizes that investigation of chronic fever in hairy cell leukemia requires a high level 
of clinical suspicion. Early diagnostic procedures for evidence of atypical mycobacterial 
infection should be considered. When everything else fails, surgery can be helpful in 
selected cases. 
Introduction 
Hairy cell leukemia (HCL) is an uncommon chronic lymphoproliferative disease in 
which malignant B-lymphocytes infiltrate bone marrow, spleen, liver and rarely lymph 
nodes. Although the survival of patients with HCL has been improved by the therapeutic 
introduction of interferon alpha and purine analogues, it is still worsened by  
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complications such as severe infections [1–3]. We present a unique case of HCL 
associated with localized splenic mycobacterial infection, and review the available 
literature. 
Case Report 
In October 2008, a 69-year-old male patient was referred for the investigation of long-lasting fatigue, 
fever (up to 39°C), sweats and nausea. Full blood count showed: hemoglobin (Hb) level 10.9 g/dl, white 
cell count (WBC) 2.4 × 10
9/l, neutrophils (NEU) 1.12 × 10
9/l, monocytes 0.02 × 10
9/l and platelets 
(PLTs) 249 × 10
9/l. Blood film, bone marrow biopsy and immunophenotyping confirmed HCL. A 
computed tomography (CT) scan showed normal lung fields and a slightly enlarged spleen. 
Initially, the patient was put on empirical piperacillin/tazobactam and amikacin which failed to 
control his fever. Cultures of blood, bone marrow, urine and induced sputum for common bacteria, 
acid-fast bacilli and Pneumocystis were negative. Serology for human immunodeficiency and hepatitis 
viruses was also negative. Quantitative real-time PCR failed to detect cytomegalovirus or Epstein-Barr 
virus transcripts in the blood. Transesophageal echocardiogram was normal. Consequently, the fever 
was considered to be a symptom of the underlying hematological disease and therapy was started. The 
patient had 4 weekly infusions of rituximab 375 mg/m
2 because he was neutropenic and then cladribine 
0.1 mg/kg/day on continuous intravenous infusion for seven days. 
Three months after admission the patient’s full blood count returned to normal (WBC/NEU 
8.6/7.5 × 10
9/l, Hb 13.6 g/dl, PLTs 166 × 10
9/l) and bone marrow immunophenotyping for minimal 
residual disease was negative (detection limit 0.1%). Nevertheless, fever and sweat persisted despite the 
successive administration of antibiotics such as quinolones, meropenem, linezolid, teicoplanin and 
liposomal amphotericin B. Empirical antimycobacterial therapy with isoniazid 600 mg/day, rifampicin 
300 mg/day and ethambutol 1,500 mg/day proved also unsuccessful. A new CT scan of the chest and 
abdomen was performed and multiple low-density lesions on the spleen and liver were detected 
(fig. 1a). Fine-needle biopsy of the liver revealed chronic nonspecific granulomatous inflammation 
while hepatic tissue cultures were sterile. Subsequently, an atypical mycobacterial infection was 
suspected and the patient was put on clarithromycin 500 mg twice daily. This intervention led only to 
partial control of symptoms, with relapses of low-grade fever still present. 
Four months after symptom onset, the patient underwent explorative laparotomy and splenectomy. 
The resected spleen had a weight of 600 g. On histological examination, splenic tissue was replaced by 
multiple necrotizing granulomata and Ziehl-Nielsen staining was positive for acid-fast bacilli (fig. 1b). 
However, cultures failed to grow mycobacteria. The patient’s fever disappeared permanently 2 days post 
operation. Antimycobacterial therapy with isoniazid, rifampicin and ethambutol was given for 
6 months. HCL remains in complete remission until now. 
Discussion 
HCL has shown a good long-term prognosis since the therapeutic introduction of 
purine analogs [2–7]. The predominant disease complication is infection, and early 
clinical studies have demonstrated a link between infection and poor survival [8, 9]. In 
patients with HCL, neutropenia and monocytopenia have been related to the occurrence 
of infection [8–10]. Additionally, in a recent study by Damaj et al., an absolute 
lymphocyte count <1 × 10
9/l at diagnosis was found to be the sole independent factor 
associated with increased risk of severe infections [3]. The relationship between 
lymphopenia and the incidence of severe infection may be explained by the fact that 
nucleoside analogs aggravate preexisting lymphopenia and immunodeficiency [3].  
Fever in HCL has been related to a wide range of infections. Half of those are caused by 
common microbes like Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus  
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pneumoniae, and Escherichia coli [11]. In the remaining half, the causative agent can be an 
intracellular pathogen (Listeria, Legionella, Coxiella, Mycobacterium tuberculosis, atypical 
mycobacteria), a fungus (Candida, Aspergillus, Cryptococcus, Rhizomucor, Sporothrix), a 
virus (hepatitis B, respiratory syncytial virus, cytomegalovirus, herpes, influenza), or a 
parasite like Toxoplasma or Pneumocystis [11]. Apart from infections, fever in HCL has 
been described in the context of vasculitis, such as polyarteritis nodosa and 
leukocytoclastic vasculitis [12]. In an early report by Bouza et al., 30% (6/20) of febrile 
patients with HCL were diagnosed with fever of unknown origin [8]. Half of these 
patients had well-documented infectious episodes later in their courses while no infection 
was found in the other half. Fever was controlled with steroids in 4/6 patients [3]. This 
could mean that fever in HCL is sometimes attributed to the disease itself. Initially, we 
believed that this was the case in our patient. This conclusion was not correct and the 
patient’s outcome highlights the need of increased clinical suspicion when investigating 
fever in HCL.  
The association between HCL and mycobacterial disease has been established [13]. To 
the best of our knowledge, a case of coexistent HCL and isolated splenic mycobacterial 
infection has never been reported in the literature. The vast majority of published reports 
describe disseminated mycobacterial disease, related to Mycobacterium kansasii infection, 
in patients with active HCL [13, 14]. Splenic granulomata due to mycobacteria are very 
rare, mostly diagnosed in immunocompomised hosts or as part of miliary tuberculosis 
[15]. This includes patients with HIV infection, organ transplantation, steroid therapy 
and chemotherapy [15]. Isolated hepatosplenic tuberculosis has been reported previously 
in the setting of acute lymphoblastic and acute myeloid leukemia [16, 17]. In both reports, 
the disease typically presented during the recovery phase of neutropenia post 
chemotherapy and was characterized by the absence of organomegaly, non-involvement 
of other sites, poor inflammatory response and a high bacillary load. It is worth noting 
that ultrasound or CT findings of such lesions, in a neutropenic individual, are not 
specific. Fungal hepatosplenic abscesss due to Candida species are included in the 
differential diagnosis, and they have been widely reported [17]. 
In conclusion, this case demonstrates that investigation of chronic fever in a patient 
with HCL requires a high level of clinical suspicion. Early diagnostic procedures for 
evidence of atypical mycobacterial infection should be considered. When everything else 
fails, surgery can be helpful in selected cases. 
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Fig. 1. a CT scan of the abdomen showing multiple low-density lesions on the spleen and liver. 
b Positive Ziehl-Nielsen staining for acid-fast bacilli on splenic tissue. 
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